Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use- Electronic Spanish Platform

Launched by BAYLOR RESEARCH INSTITUTE · Jul 25, 2022

Keywords

ClinConnect Summary

This study is testing whether a Spanish-language electronic screening tool called TAPS-ESP can accurately identify people who use tobacco, alcohol, prescription drugs, or illicit substances in a primary care setting. Researchers will compare TAPS-ESP results with a standard diagnostic interview to see how well the tool detects any level of substance use and different levels of risk, from casual use to a possible substance use disorder.

People who may join are adults 18 and older who are patients at Baylor Scott & White Community Care in Dallas, prefer Spanish, and can read Spanish. Participants will be randomly assigned to one of two ways of using the tool: they either complete TAPS-ESP on an iPad first and then have an interviewer-administered assessment, or start with the interview and then complete TAPS-ESP themselves. The study plans to enroll about 1,000 people and will follow participants for about a year. This is a screening and validation study (not a drug trial), and there are no medicines given. If someone cannot consent, cannot read Spanish, or cannot use the iPad, they would not be eligible. The trial is ongoing, with results expected after completion.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18 or older
• • Current patient of the clinic
• • Spanish-language preferred
• • Ability to read Spanish
• Exclusion Criteria:
• • Unable to provide informed consent
• • Inability to comprehend or read Spanish
• • Inability to self-administer the iPad tool due to physical limitations